ATE345815T1 - Kombinierte impfstoffe gegen hepatitis a und hepatitis b - Google Patents

Kombinierte impfstoffe gegen hepatitis a und hepatitis b

Info

Publication number
ATE345815T1
ATE345815T1 AT99924871T AT99924871T ATE345815T1 AT E345815 T1 ATE345815 T1 AT E345815T1 AT 99924871 T AT99924871 T AT 99924871T AT 99924871 T AT99924871 T AT 99924871T AT E345815 T1 ATE345815 T1 AT E345815T1
Authority
AT
Austria
Prior art keywords
hepatitis
vaccines against
combined vaccines
combined
against hepatitis
Prior art date
Application number
AT99924871T
Other languages
English (en)
Inventor
Claude Artois
Michael J Clark
Clothilde Thiriart
Stefan Gabriel Jozef Thoelen
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE345815T1 publication Critical patent/ATE345815T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99924871T 1998-05-01 1999-04-27 Kombinierte impfstoffe gegen hepatitis a und hepatitis b ATE345815T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9809507.8A GB9809507D0 (en) 1998-05-01 1998-05-01 Novel composition

Publications (1)

Publication Number Publication Date
ATE345815T1 true ATE345815T1 (de) 2006-12-15

Family

ID=10831426

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99924871T ATE345815T1 (de) 1998-05-01 1999-04-27 Kombinierte impfstoffe gegen hepatitis a und hepatitis b

Country Status (29)

Country Link
EP (1) EP1073462B1 (de)
JP (2) JP5138843B2 (de)
KR (1) KR100612547B1 (de)
CN (1) CN1263509C (de)
AR (1) AR016987A1 (de)
AT (1) ATE345815T1 (de)
AU (1) AU743759B2 (de)
BR (1) BR9910157A (de)
CA (1) CA2331086C (de)
CO (1) CO5050367A1 (de)
CY (1) CY1107322T1 (de)
CZ (1) CZ301232B6 (de)
DE (1) DE69934108T2 (de)
DK (1) DK1073462T3 (de)
ES (1) ES2277437T3 (de)
GB (1) GB9809507D0 (de)
GC (1) GC0000101A (de)
HK (1) HK1034202A1 (de)
HU (1) HU228209B1 (de)
IL (1) IL139269A0 (de)
MY (1) MY128929A (de)
NO (1) NO20005483L (de)
NZ (1) NZ507902A (de)
PL (1) PL190729B1 (de)
PT (1) PT1073462E (de)
TR (1) TR200003235T2 (de)
TW (1) TW553744B (de)
WO (1) WO1999056772A2 (de)
ZA (1) ZA200006118B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1513555A (zh) * 2003-07-31 2004-07-21 长春生物制品研究所 甲-乙型肝炎联合疫苗及其冻干制剂
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
CN102198270B (zh) * 2011-05-16 2012-06-27 大连汉信生物制药有限公司 一种含铝佐剂乙肝疫苗的制备方法
KR101281098B1 (ko) * 2011-06-30 2013-07-02 주식회사 녹십자 Ｂ형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도
CN102988975A (zh) * 2012-11-30 2013-03-27 深圳康泰生物制品股份有限公司 甲型、乙型肝炎联合疫苗及其制备方法
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0349686A (ja) * 1989-07-11 1991-03-04 Smithkline Biologicals Sa レトロウイルスｇａｇ蛋白の真核生物細胞における発現
JP3626996B2 (ja) * 1992-05-23 2005-03-09 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム Ｂ型肝炎表面抗原および他の抗原からなる複合ワクチン
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
US6372225B1 (en) * 1996-03-23 2002-04-16 The Research Foundation Of Microbial Diseases Of Osaka University Tetanus toxin functional fragment antigen and tetanus vaccine

Also Published As

Publication number Publication date
CN1263509C (zh) 2006-07-12
HK1034202A1 (en) 2001-10-19
TR200003235T2 (tr) 2001-03-21
TW553744B (en) 2003-09-21
KR100612547B1 (ko) 2006-08-11
NZ507902A (en) 2002-03-28
NO20005483L (no) 2000-12-08
CY1107322T1 (el) 2012-11-21
PL344137A1 (en) 2001-10-08
ZA200006118B (en) 2002-01-30
HU228209B1 (en) 2013-01-28
CO5050367A1 (es) 2001-06-27
AU4137999A (en) 1999-11-23
MY128929A (en) 2007-02-28
CZ20004061A3 (cs) 2001-04-11
JP5138843B2 (ja) 2013-02-06
JP2010209118A (ja) 2010-09-24
AR016987A1 (es) 2001-08-01
GB9809507D0 (en) 1998-07-01
JP2002513771A (ja) 2002-05-14
DK1073462T3 (da) 2007-02-26
CZ301232B6 (cs) 2009-12-16
NO20005483D0 (no) 2000-10-31
CA2331086C (en) 2010-06-22
ES2277437T3 (es) 2007-07-01
WO1999056772A2 (en) 1999-11-11
KR20010043224A (ko) 2001-05-25
BR9910157A (pt) 2001-01-09
CA2331086A1 (en) 1999-11-11
HUP0101652A1 (hu) 2001-09-28
HUP0101652A3 (en) 2004-10-28
GC0000101A (en) 2005-06-29
PT1073462E (pt) 2007-01-31
WO1999056772A3 (en) 2000-02-03
PL190729B1 (pl) 2005-12-30
DE69934108D1 (de) 2007-01-04
EP1073462A2 (de) 2001-02-07
DE69934108T2 (de) 2007-04-19
EP1073462B1 (de) 2006-11-22
CN1308547A (zh) 2001-08-15
IL139269A0 (en) 2001-11-25
AU743759B2 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
ATE335509T1 (de) Hib/dtpa impfstoff und herstellungsmethoden
ATE323509T1 (de) Impfstoff gegen hbv und hpv
DE50112013D1 (de) Deodorantien und antiperspirantien
ATE357252T1 (de) Adjuvanzsysteme und impfstoffe
NO20003303D0 (no) Vaksine
ATE209045T1 (de) Hepatitis b impfstoff
ID26599A (id) Turunan triazola dan imidazola
DE60021260D1 (de) Wassergetragene vulkanisierbare fluorgummimischungen und damit beschichteter gegenstand
AR028343A1 (es) Derivados de pirrolidina y piperidina
ID28721A (id) Bidang luncur dan pinston untuk mesin pembakaran dalam
DE60001107D1 (de) Sichere und handliche hinweisanordung
DE50100186D1 (de) Boiler und Dampfgargerät mit einem derartigen Boiler
DE60029075D1 (de) Kopiergerät und Kopierverfahren
FI20001715A0 (fi) Rankoihin liittyvät järjestelyt ja menetelmät
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
DE60223540D1 (de) Mundschutz und mundschutzfolie
ATE345815T1 (de) Kombinierte impfstoffe gegen hepatitis a und hepatitis b
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
NO20024617D0 (no) Aryl- og heteroarylsulfonater
ATE333894T1 (de) Vakzine gegen infektiöse bursitis
DE60022990D1 (de) Markierungsfolie und verbundmarkierungsfolie
ATE431415T1 (de) Hiv impfstoff
DE60005282D1 (de) Golfschlägerkopf, golfschläger und golfschlägerset
DE29722200U1 (de) Größen- und formveränderbares Bekleidungsstück

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1073462

Country of ref document: EP